BioStable Science & Engineering, a medical technology company focused on products for aortic valve repair for the treatment of aortic insufficiency, announced today the initial closing of its Series C equity financing.
BioStable Science & Engineering, Inc., a medical technology company focused on products for aortic valve repair for the treatment of aortic insufficiency, today announced that over 500 patients worldwide have now been treated using the HAART Aortic Annuloplasty Device.
Heart valve surgeon providing patients with innovative options Article by Ryan Trares of the Daily Journal. "Chris Pagano faced surgery to fix a leaking aortic valve in early January. The New Whiteland resident had blood pumping back into his heart, putting him at risk for heart failure. Though he had confidence in his surgical team, he couldn’t help but consider what would happen to his wife Kari and 8-year-old daughter, Kinley, if the procedure [...]
Breakthrough Innovation: The HAART Aortic Annuloplasty Device Cleared by the FDA Article by Adam Pick - Patient, Author & HeartValveSurgery.com Founder "A renaissance is taking place in the world of aortic valve repair. While patients have benefited from advances in mitral valve repair procedures (long-term durability, freedom from re-operation and normal life expectancy), reproducing those results using aortic valve repair techniques has been challenging. Unfortunately, patients with aortic valve regurgitation – also known as [...]
A New Tool to Treat Aortic Valve Disease - First surgery in South Carolina to use FDA approved HAART 300 Aortic Annuloplasty Device. Video from WIS-TV in Columbia, SC.